Table 1.
Congenital Heart Disease | Cardiomyopathy | |
---|---|---|
Differences | ||
Phenotype | Wide spectrum of cardiac malformations including the valves, septa, and great vessels | Dilation or hypertrophy of the myocardium +/− disease of the conduction system; results in HF or SCD |
Expression | Present at birth by definition | Typical disease onset is in adolesence or adulthood, but can express at any age |
Genetics | LoF mutations in transcription factor genes and other signaling molecules that disturb molecular pathways during cardiac development | Mutations in structural genes involving proteins of the sarcomere, cellular cytoskeleton, or ion channels |
Population Attributable Risk of Genetic Causes | 5–10% | 50–70% |
Clinical Genetic Testing | Not recommended except in rare syndromic cases | Recommended in most familial cases |
Similarities | ||
Phenotype | Several syndromes with CHD and congenital CMP; Co-occurrence of LVNC with CHD | |
Expression | Congenital cardiomyopathies occurring in the setting of CHD | |
Genetics | Multiple shared pathways between heart development and myocardial disease; Few genes that cause both CHD and congenital CMP; Multiple genes that cause CHD have altered expression in the setting of heart failure |
HF Heart Failure, SCD Sudden Cardiac Death, LoF Loss of Function, CHD Congenital Heart Disease, CMP Cardiomyopathy, LVNC Left Ventricular Non-Compactum